English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

P368 Serological response to the 23-valent pneumococcal polysaccharide vaccine in patients with Crohn’s disease: preliminary results of a prospective, multicentre study C.K. Lee1 *, H.-S. Kim2, H.-J. Kim1, W. Moon3, K.M. Lee4, J.-S. Koo5, G.S. Seo6, S.J. Park7, B.D. Ye8, C.H. Choi9, S.-A. Jung10, Y.S. Kim11, J.P. Im12, E.S. Kim13, S.N. Hong14. 1Kyung Hee University, South Korea, 2Yonsei University Wonju College of Medicine, South Korea, 3Kosin University, South Korea, 4The Catholic University of Korea, South Korea, 5Korea University, South Korea, 6Wonkwang University, South Korea, 7Yonsei University, South Korea, 8University of Ulsan, South Korea, 9Chung-Ang University, South Korea, 10Ewha Womans University, South Korea, 11Inje University, South Korea, 12Seoul National University, South Korea, 13Keimyung University, South Korea, 14Konkuk University, South Korea

journal of crohn's and colitis

P368 Serological response to the 23-valent pneumococcal polysaccharide vaccine in patients with Crohn's disease: preliminary results of a prospective, multicentre study